N.S. Strekalova, D.A. Kuznetsov
Ryazan State Medical University named after I.P. Pavlov, Ministry of Health of the Russian Federation, Ryazan
Abstract. The aim of the study was to review regulatory
documents on pharmaceuticals’ pricing, to analyze results of price
monitoring for essential drugs in the Tambov region both at the
outpatient and inpatient segments of the pharmaceutical market.
To study the topic the following questions were considered:
- What normative documents regulate pricing of pharmaceuticals in the Russian Federation?
- How does the government control pricing and range of pharmaceuticals in the regions of the Russian Federation?
- What is dynamics of prices on essential drugs in Tambov region?
- How effective is the current legislation related to pricing of essential drugs?
The study used system-view approach, methods of statistical analysis and extrapolation.
Research objects included: pharmaceutical organizations of different
legal structures in Tambov region, data of the Tambov region Healthcare
Department, legal and regulatory instruments related to pricing of
pharmaceuticals.
Results of the study included the following:
- In 2010, in the Tambov region international and domestic
pharmaceuticals of outpatient and inpatient segment of different prices
cheapened;
- In 2011, price of pharmaceuticals slightly increased because many
pharmacies tried to gain maximum retail margin on essential drugs to
increase retail sales;
- In 2012, a slight growth of purchasing prices of inpatient
pharmaceuticals as well as prices of outpatient essential drugs of the
cheapest price segment (pharmaceuticals priced under 50 rubles) was
reported;
- In 2013, the Tambov region witnessed decrease in prices of
international and domestic essential drugs of all price segments of both
outpatient and inpatient purposes.
Keywords: legal regulation; monitoring of pharmaceuticals’ prices.
References:
- Vital and essential medicines: cardiovascular system. [Internet]
[cited 2014 Apr 14]. Available from:
http://www.remedium.ru/section/state (In Russian).
- Amendments to the List of vital and essential medicines (VEM) for
2011 approved by the Regulation of the Government of the Russian
Federation of 2010 November 11 ¹1938-r", by VEM packages, which prices
have been included in the State Register of maximum wholesale prices for
the medicines included in the VEM List (by the state of 2011 December
15): Regulation of the Government of the Russian Federation of 2010
November 11. ¹1938-r (the edition of Regulation of the Government of the
Russian Federation of 2011 November 03 ¹1933-r). [Internet] [cited 2014
Apr 14]. Available from: http://www.zakonprost.ru/content/base/175257
(In Russian).
- On the government regulation of prices for medicines included in
the List of vital and essential medicines: Regulation of the Government
of the Russian Federation of 2010 October 29 ¹ 865. [Internet] [cited
2014 Apr 15]. Available from:
http://www.rosminzdrav.ru/documents/7459-postanovlenie-pravitelstva-rf-865-ot-29-oktyabrya-2010-g
(In Russian).
- Improvement of government regulation of prices for vital and
essential medicines: Regulation of the Government of the Russian
Federation of 2009 August 08 ¹ 654. [Internet] [cited 2014 Apr 12].
Available from: http://www.rg.ru/2009/08/14/lekarstva-dok.html (In
Russian).
- Organization and implementation of monitoring of assortment and
prices for vital and essential medicines: the Order of the Ministry of
Health and Social Development of the Russian Federation of 2009 May 27 ¹
277n. [Internet] [cited 2014 Apr 14]. Available from: http://base.garant.ru/4188416/ (In Russian).
- On developing the List of vital and essential medicines for 2013:
Regulation of the Government of the Russian Federation of 30.07.2012 ¹
1378-r. [Internet] [cited 2014 Apr 14]. Available from:
http://www.consultant.ru/document/cons_doc_LAW_133531/ (In Russian).
- On approval of the Regulations of the Federal Service on
supervision in health care: Regulation of the Government of the Russian
Federation of 2004 June 30. ¹ 323. [Internet] [cited 2014 Apr 14].
Available from: http://base.garant.ru/12135989/ (In Russian).
- On approval of the List of vital and essential medicines:
Regulation of the Government of the Russian Federation of 2009 December
30 ¹ 2135-r. Regulation of the Government of the Russian Federation
[Internet] [cited 2014 Apr 12]. Available from:
http://base.garant.ru/12172129/ (In Russian).
- On approval of the List of vital and essential medicines for 2012:
Regulation of the Government of the Russian Federation of 2011 December
07, ¹ 2199-r. [Internet] [cited 2014 Apr 15]. Available from:
http://www.rosminzdrav.ru/documents/7008-rasporyazhenie-pravitelstva-rf-2199-r-ot-7-dekabrya-2011-g
(In Russian).
- Strekalova N.S., Kuznetsov D.A. Monitoring of prices in
pharmaceutical market in Tambov region compared to the Russian
Federation. Universitetskaya nauka: vzglyad v budushcheå. 2013; (2):
141-144. (In Russian).
- Strekalova N.S., Kuznetsov D.A. Regional aspects of monitoring of
medicine prices (in Tambov region). “Human and medicine” XVIII Russian
national congress. Moscow, April 11-15, 2011. Theses of reports. Moscow.
2011. p. 636. (In Russian).
- Strekalova N.S., Kuznetsov D.A. Analysis of results of monitoring
of VEM price accessibility at a regional level. «Human and medicine» XXI
Russian national congress. Moscow, April 7-11, 2014. Theses of reports.
Moscow. 2014. p. 434. (In Russian).
- Sura M.V., Omel'yanovskiy V.V. Evolution of the expertise system at development of the List of vital and essential medicines. Meditsinskie tekhnologii. Otsenka i vybor. 2011; (3): 30-33. (In Russian).
- Charchyan B.E., Uvarov V.V. Management of price policy of pharmaceutical companies in the Russian market. Rossiyskiy vneshneekonomicheskiy vestnik. 2011; (2): 50-58. (In Russian).
Views: 16090
|